In a finding that suggests sooner is better than later, a new trial shows that giving advanced treatment early to Crohn’s patients can dramatically improve their gut health. About 80% of those who got therapy with an immune-suppressing drug called infliximab shortly after their Crohn’s diagnosis experienced an improvement in their symptoms and inflammatory markers related to the disease, researchers report.

Source: HealthDay